ProfileGDS5678 / 1418210_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 98% 98% 98% 97% 97% 98% 98% 98% 98% 98% 98% 98% 98% 98% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 19.8483598
GSM967853U87-EV human glioblastoma xenograft - Control 29.8368598
GSM967854U87-EV human glioblastoma xenograft - Control 39.7526698
GSM967855U87-EV human glioblastoma xenograft - Control 49.5123997
GSM967856U87-EV human glioblastoma xenograft - Control 59.5580897
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 19.8708498
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 29.7688498
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 39.6133198
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 49.7933698
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 19.7405998
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 29.9770298
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 39.7427698
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 49.7399498
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 59.7530998